Huanghua Zhongmu Biotechnology Co., Ltd. is a biotechnology company established in 2019, located in Hebei Province, China. The company specializes in the production of bovine bone-derived products such as bovine bone collagen, collagen peptides, and chondroitin peptides, primarily for the health and medical industries. They source raw materials from countries like Australia, New Zealand, Uruguay, and Argentina. The company collaborates with Tianjin University of Science and Technology and other research institutes to drive innovation. Their products are exported to markets in North America, Europe, Asia, and beyond.